Andreas Engert
Impact in
- Pathology and Forensic Medicine top 0.01%
- Lymphoma Diagnosis and Treatment
- Genetics top 0.1%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 408
- Genetics 107
- Chronic Lymphocytic Leukemia Research 95
- Co-authors
- Volker Diehl (196 shared papers)Peter Borchmann (180 shared papers)Dennis Alexander Eichenauer (72 shared papers)Andreas Josting (60 shared papers)Bastian von Tresckow (94 shared papers)Michael Fuchs (103 shared papers)H. Schulz (21 shared papers)Julia Bohlius (30 shared papers)
- Journals
- Blood (133 papers)Journal of Clinical Oncology (54 papers)Annals of Oncology (49 papers)Cochrane Database of Systematic Reviews (32 papers)British Journal of Haematology (18 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Andreas Engert
576 papers receiving 27.5k citations
Andreas Engert's Hit Papers
Peers
Comparison fields: 5 of 158
- Pathology and Forensic Medicine 16.5k
- Genetics 4.7k
- Oncology 10.3k
- Neurology 5.4k
- Immunology 4.7k
Countries citing papers authored by Andreas Engert
This map shows the geographic impact of Andreas Engert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Engert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Engert more than expected).
Fields of papers citing papers by Andreas Engert
This network shows the impact of papers produced by Andreas Engert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Engert. The network helps show where Andreas Engert may publish in the future.
Co-authors
The 25 scholars most cited alongside Andreas Engert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 601 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma Hit paper breakdown → | 2012 | 1212 |
| 2 | Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial Hit paper breakdown → | 2016 | 774 |
| 3 | Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma Hit paper breakdown → | 2010 | 707 |
| 4 | 1999 | 573 | |
| 5 | Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial Hit paper breakdown → | 2018 | 562 |
| 6 | Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial Hit paper breakdown → | 2012 | 466 |
| 7 | Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials Hit paper breakdown → | 2009 | 462 |
| 8 | 2006 | 437 | |
| 9 | 2009 | 374 | |
| 10 | Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Hit paper breakdown → | 2014 | 371 |
| 11 | 2003 | 343 | |
| 12 | 2003 | 341 | |
| 13 | 2010 | 330 | |
| 14 | 2016 | 320 | |
| 15 | 2007 | 294 | |
| 16 | 2018 | 291 | |
| 17 | 2015 | 281 | |
| 18 | 2017 | 270 | |
| 19 | 2017 | 259 | |
| 20 | 2003 | 252 |
About Andreas Engert
Andreas Engert is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Pulmonary and Respiratory Medicine and Neurology, having authored 601 papers that have together received 28.7k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (408 papers), Lung Cancer Treatments and Mutations (126 papers), Chronic Lymphocytic Leukemia Research (95 papers), CNS Lymphoma Diagnosis and Treatment (74 papers), Viral-associated cancers and disorders (55 papers), Monoclonal and Polyclonal Antibodies Research (51 papers), Toxin Mechanisms and Immunotoxins (37 papers) and Immune Cell Function and Interaction (36 papers). The work is most often cited by research in Pathology and Forensic Medicine (16.5k citations), Genetics (4.7k citations), Oncology (10.3k citations), Neurology (5.4k citations) and Immunology (4.7k citations). Andreas Engert has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Volker Diehl, Peter Borchmann, Dennis Alexander Eichenauer, Andreas Josting, Bastian von Tresckow, Michael Fuchs, H. Schulz, Julia Bohlius, Anas Younes and Thomas Elter. Their work appears in journals such as Blood, Journal of Clinical Oncology, Annals of Oncology, Cochrane Database of Systematic Reviews and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.